Literature DB >> 36210410

Effect of Glycodelin on the Cytokine Profile of Rats during Allogeneic Bone Marrow Cell Transplantation.

M S Bochkova1,2, V P Timganova3, K Yu Shardina3, S V Uzhviyuk3, N P Loginova4, Ya N Troinich4, S A Zamorina3,5.   

Abstract

The protein glycodelin (PP14, PAEP) is associated with pregnancy and exhibits pronounced immunotropic properties. We studied the effect of glycodelin on the cytokine profile of blood serum during transplantation a suspension of allogeneic red bone marrow cells to Wistar rats. Recombinant glycodelin was administered to the animals 4 times (14 μg each time). Against the background of bone marrow cell transplantation, the levels of proinflammatory (IL-1α, IL-1β, and IL-18) and regulatory (IL-7, IL-12) cytokines and CSF (M-CSF) increased in blood serum, which indicates a systemic inflammatory response to the allograft. Glycodelin administration against the background of bone marrow cell allotransplantation led to a significant decrease in the proinflammatory cytokine IL-17A on day 21 of the experiment; the concentrations of the other cytokines remained unchanged. In general, glycodelin can suppress the level of IL-17A, a marker of graft rejection, which opens perspectives for its further investigation as a potential drug.
© 2022. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Wistar rats; allogeneic transplant; cytokine profile; glycodelin

Mesh:

Substances:

Year:  2022        PMID: 36210410     DOI: 10.1007/s10517-022-05603-2

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.737


  11 in total

1.  Prolongation of liver allograft survival after interleukin-10 gene transduction 24-48 hours before donation.

Authors:  H Tashiro; K Shinozaki; H Yahata; K Hayamizu; T Okimoto; H Tanji; Y Fudaba; H Yamamoto; X Fan; H Ito; T Asahara
Journal:  Transplantation       Date:  2000-07-27       Impact factor: 4.939

Review 2.  Cytokines in Graft-versus-Host Disease.

Authors:  Andrea S Henden; Geoffrey R Hill
Journal:  J Immunol       Date:  2015-05-15       Impact factor: 5.422

3.  Immunomodulatory activity of glycodelin: implications in allograft rejection.

Authors:  A Dixit; B Balakrishnan; A A Karande
Journal:  Clin Exp Immunol       Date:  2018-01-18       Impact factor: 4.330

4.  Graft-versus-host reactions mediated by spleen cells from amyloidotic and nonamyloidotic mice.

Authors:  F Hardt; M H Claësson
Journal:  Transplantation       Date:  1971-07       Impact factor: 4.939

5.  Plasma levels of IL-7 and IL-15 in the first month after myeloablative BMT are predictive biomarkers of both acute GVHD and relapse.

Authors:  S Thiant; I Yakoub-Agha; L Magro; J Trauet; V Coiteux; J-P Jouet; J-P Dessaint; M Labalette
Journal:  Bone Marrow Transplant       Date:  2010-03-01       Impact factor: 5.483

Review 6.  Cytokines of the IL-1 family: recognized targets in chronic inflammation underrated in organ transplantations.

Authors:  Ilja Striz
Journal:  Clin Sci (Lond)       Date:  2017-08-10       Impact factor: 6.124

7.  The roles of T helper type 17/regulatory T cells in acute rejection after liver transplantation in rats.

Authors:  Yaxing Zhou; Xiaojun Yang; Hai Zhang; Jianguo Jiang
Journal:  Transplantation       Date:  2015-06       Impact factor: 4.939

Review 8.  Role of IL-18 in transplant biology.

Authors:  Chen Liu; Juntao Chen; Baoqing Liu; Shunzong Yuan; Dawei Shou; Liang Wen; Xiaoying Wu; Weihua Gong
Journal:  Eur Cytokine Netw       Date:  2018-06-01       Impact factor: 2.737

9.  The role of glycodelin as an immune-modulating agent at the feto-maternal interface.

Authors:  Anshula Alok; Anjali A Karande
Journal:  J Reprod Immunol       Date:  2009-11-05       Impact factor: 4.054

Review 10.  Immune Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Justyna Ogonek; Mateja Kralj Juric; Sakhila Ghimire; Pavankumar Reddy Varanasi; Ernst Holler; Hildegard Greinix; Eva Weissinger
Journal:  Front Immunol       Date:  2016-11-17       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.